Get the Stockscreener App
0.1961
3.72%
-0.0111
Genprex Inc stock is traded at $0.1961, with a volume of 674.62K.
It is down -3.72% in the last 24 hours and up +20.91% over the past month.
Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.
See More
Previous Close:
$0.2072
Open:
$0.202
24h Volume:
674.62K
Relative Volume:
0.08
Market Cap:
$8.56M
Revenue:
-
Net Income/Loss:
$-22.71M
P/E Ratio:
-0.0167
EPS:
-11.71
Net Cash Flow:
$-18.24M
1W Performance:
-18.40%
1M Performance:
+20.91%
6M Performance:
-48.33%
1Y Performance:
-43.05%
1-Day Range:
$0.1922
$0.202
1-Week Range:
$0.1922
$0.2458
52-Week Range:
$0.14
$3.97
Genprex Inc Stock (GNPX) Company Profile
Name
Genprex Inc
Sector
Industry
Phone
512-537-7997
Address
1601 TRINITY STREET, BLDG. B, AUSTIN, TX
Compare GNPX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GNPX
Genprex Inc
|
0.1995 | 9.45M | 0 | -22.71M | -18.24M | -11.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
381.99 | 97.36B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
576.20 | 60.19B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.86 | 59.56B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
718.13 | 44.94B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
330.98 | 36.14B | 3.81B | -644.79M | -669.77M | -6.24 |
Genprex Inc Stock (GNPX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-26-21 | Initiated | National Securities | Buy |
| Apr-29-19 | Initiated | Noble Capital Markets | Outperform |
Genprex Inc Stock (GNPX) Latest News
How high can Genprex Inc. stock goPortfolio Update Report & Verified Technical Trade Signals - newser.com
Risk vs reward if holding onto Genprex Inc.2025 Macro Impact & AI Driven Stock Movement Reports - newser.com
What the charts say about Genprex Inc. today2025 Technical Overview & Reliable Volume Spike Alerts - newser.com
Does Genprex Inc. fit your quant trading modelTreasury Yields & Fast Entry Momentum Trade Alerts - newser.com
Using economic indicators to assess Genprex Inc. potentialJuly 2025 Intraday Action & Capital Efficient Trading Techniques - newser.com
Applying Elliott Wave Theory to Genprex Inc.2025 Price Momentum & Risk Controlled Stock Alerts - newser.com
Will Genprex Inc. rebound enough to break evenQuarterly Trade Summary & Real-Time Volume Surge Alerts - newser.com
Volatility clustering patterns for Genprex Inc.July 2025 Trends & Free Weekly Chart Analysis and Trade Guides - newser.com
Can trapped investors hope for a rebound in Genprex Inc.2025 Technical Overview & Accurate Intraday Trade Tips - newser.com
When is the best time to exit Genprex Inc.Market Activity Summary & Community Consensus Stock Picks - newser.com
Analyzing net buyer seller activity in Genprex Inc.Trade Volume Summary & Advanced Technical Analysis Signals - newser.com
Does Genprex Inc. qualify in momentum factor screeningMarket Performance Summary & Advanced Technical Signal Analysis - newser.com
Movement Recap: Will Riley Exploration Permian Inc. outperform its industry peersDollar Strength & Real-Time Stock Price Movement Reports - خودرو بانک
Will Genprex Inc. benefit from macro trendsEarnings Recap Summary & Short-Term High Return Strategies - newser.com
New Highs: Can Genprex Inc. lead its sector in growthJuly 2025 Rallies & Safe Capital Investment Plans - خودرو بانک
Market Overview: Is Genprex Inc stock undervalued right nowQuarterly Portfolio Review & AI Powered Buy/Sell Recommendations - خودرو بانک
US Market Wrap: Should I hold or sell Baiya International Group Inc. nowWeekly Trend Summary & Proven Capital Preservation Tips - خودرو بانک
Risk Report: Is Genprex Inc. stock undervalued right now2025 Momentum Check & AI Forecasted Stock Moves - خودرو بانک
Stock Market Recap: How does Genprex Inc score in quality rankingsPortfolio Update Report & Fast Exit/Entry Strategy Plans - خودرو بانک
Volatility Watch: Is Ascent Solar Technologies Inc. forming a double bottom2025 Key Lessons & Real-Time Chart Pattern Alerts - خودرو بانک
Can you recover from losses in Genprex Inc.Quarterly Profit Summary & Weekly High Conviction Ideas - newser.com
Bearish Setup: Whats Genprex Incs historical return2025 Biggest Moves & Technical Entry and Exit Tips - خودرو بانک
Aug Final Week: Is MDCXW stock technically oversoldTrade Signal Summary & Risk Adjusted Buy/Sell Alerts - خودرو بانک
Analysis Recap: Is Genprex Inc stock risky to hold nowJuly 2025 Short Interest & Expert Curated Trade Setups - خودرو بانک
Take Profit: Is VSTM a momentum stockWeekly Market Summary & Free Community Supported Trade Ideas - خودرو بانک
Will Genprex Inc. continue its uptrendTrade Signal Summary & Real-Time Stock Price Movement Reports - Newser
Identifying reversal signals in Genprex Inc.Trade Analysis Summary & Stepwise Trade Signal Guides - Newser
Genprex (GNPX) Files to Sell 25 Million Common Shares - GuruFocus
Quantitative breakdown of Genprex Inc. recent move2025 Investor Takeaways & Weekly Consistent Profit Watchlists - Newser
What machine learning models say about Genprex Inc.Quarterly Profit Review & Target Return Focused Stock Picks - Newser
Institutional scanner results for Genprex Inc.July 2025 Weekly Recap & Stock Portfolio Risk Control - Newser
Genprex files to sell 25M shares of common stock by selling shareholders - MSN
Genprex Inc Stock (GNPX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.20%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):